September 2025 in “Cancer Innovation” This study argues for "clinical trial re-innovation," highlighting new designs like basket, umbrella, and platform trials that incorporate biomarker technologies to meet the dynamic needs of precision medicine, potentially enabling more effective, patient-specific treatments and overcoming limitations of traditional disease-centered trials.
February 2025 in “PubMed” This study evaluated an AI-driven system for personalizing non-medicated hair loss treatments in women, showing significant improvements in hair growth, shedding, texture, and scalp health over 24 weeks, with no adverse effects reported.
1 citations
,
June 2018 in “JAMA Dermatology” This abstract does not contain specific research findings or results, but instead provides information related to the JAMA Dermatology journal's online platform and services.
1 citations
,
February 2026 in “ACS Nano” This study developed the TLMG hydrogel, a seamless in situ biointerface platform, demonstrating robust adhesion, high conductivity, and therapeutic effects for intelligent wound management in complex animal models and human tests, indicating its promise for integrated bioelectronic medicine.
February 2024 in “Cosmetics” In this study, researchers developed a novel platform for discovering potential hair loss inhibitors by investigating the testosterone/dihydrotestosterone biosynthetic pathway and its regulation through biochemical mechanisms involving 17β-HSD and 3β-HSD, combined with medicinal plant extracts.
